510(k) K062109

BINAXNOW INFLUENZA A & B TEST by Binax, Inc. — Product Code PSZ

K062109 is an FDA 510(k) premarket notification submitted by Binax, Inc. for the device "BINAXNOW INFLUENZA A & B TEST". The FDA issued a decision of Substantially Equivalent on Nov 9, 2006. The device falls under product code PSZ (Devices Detecting Influenza A, B, And C Virus Antigens), a Class II device regulated under 21 CFR 866.3328. Binax, Inc. has 29 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Nov 9, 2006
Date Received
Jul 24, 2006
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Devices Detecting Influenza A, B, And C Virus Antigens
Device Class
Class II
Regulation Number
866.3328
Review Panel
MI
Submission Type
510(k)

An influenza virus antigen detection test system is a device intended for the qualitative detection of influenza viral antigens directly from clinical specimens in patients with signs and symptoms of respiratory infection.

Need the full FDA record for Binax, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K062109. Report a data issue: hello@regdatalab.com.